Sumatriptan
35 NDCs across 15 manufacturers|28 Generic,7 Brand
Sumatriptan is used to treat cluster headache and migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 26, 1997, and the first generic was approved Feb 19, 2016. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $9 million on Sumatriptan across 49,000 claims for 15,000 beneficiaries.
Sumatriptan is available as 35 NDCs from 15 manufacturers (28 generic, 7 brand), with NADAC prices from $0.24 to $108.22 per EA — the most expensive product costs about 452× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
35
28G / 7B
Manufacturers
15
competing in market
Price Spread
$0.24 – $108.22
per EA, 27 of 35 NDCs
7d Activity
avg -1.6% WoW · of 35 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Rising Pharma Holdings Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
15 manufacturers producing SUMATRIPTAN(6 pricing outliers)
Frequently Asked Questions
What is Sumatriptan used to treat?
Sumatriptan is used to treat cluster headache and migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Sumatriptan become available as a generic?
FDA approved the first generic Sumatriptan (ANDA) on Feb 19, 2016. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Sumatriptan?
In 2024, Medicare Part D spent $9 million on Sumatriptan across 49,000 claims for 15,000 beneficiaries.
How many Sumatriptan products are on the market?
The Sumatriptan drug market contains 35 NDCs from 15 manufacturers — 28 generic and 7 brand products.
What is the price range for Sumatriptan?
NADAC reference prices for Sumatriptan range from $0.2394 to $108.2212 per EA — the most expensive product costs about 452× the cheapest. 8 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Sumatriptan cheaper than brand?
The average generic NADAC for Sumatriptan is $6.0027 per EA, versus $90.4768 for brand-labeled products — brand versions average about 15× the generic price.
Which manufacturers make Sumatriptan?
15 manufacturers list Sumatriptan in NADAC. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (9), GlaxoSmithKline LLC (5), Bionpharma Inc. (3), Sun Pharmaceutical Industries Inc. (3), Prasco Laboratories (2).
How has the price of Sumatriptan changed recently?
Over the past 7 days, 8 Sumatriptan NDCs rose and 18 fell, with a market-wide average change of -1.6%.